Foundation-funded research is supporting the development of a wearable sensor that monitors biomarkers of inflammation in a patient’s sweat by EnLiSense. The company is developing a device that measures levels of C-reactive protein, IL-6, TNF, and calprotectin in the sweat that forms on the skin during normal daily activities. This project is funded through the Foundation’s venture philanthropy program, IBD Ventures, which supports product-oriented research and development to address unmet patient needs.